Financials

  • Market Capitalization 393.91 M
  • Employee 752
  • Founded 2014
  • CEO Christian Itin
  • Website www.autolus.com
  • Headquarter United Kingdom
  • FIGI BBG00KVT05R6
  • Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-1.84
Price to sales ratio
7.03

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
3101
IPSC
Century Therapeutics, Inc. - Common Stock
2.20 USD-2.22%-8.33%-5.58%+272.88%396.78 M USD
3102
ENTA
Enanta Pharmaceuticals, Inc. - Common Stock
13.64 USD-0.44%-6.96%+14.14%+95.70%396.63 M USD
3121
LRMR
Larimar Therapeutics, Inc. - Common Stock
3.73 USD-12.85%+11.34%+6.27%+6.27%387.48 M USD
3129
XFOR
X4 Pharmaceuticals, Inc. - Common Stock
4.05 USD-8.16%+0.50%-0.74%+36.36%381.99 M USD

Frequently asked questions about Autolus Therapeutics plc - American Depositary Shares

What is the Autolus Therapeutics plc - American Depositary Shares stock price today?

The current price of Autolus Therapeutics plc - American Depositary Shares (AUTL) is 1.48. Over the past 24 hours, the stock has changed by -8.07%. Follow the AUTL chart for real-time price dynamics.

What is the stock ticker of Autolus Therapeutics plc - American Depositary Shares?

Autolus Therapeutics plc - American Depositary Shares trades under the ticker AUTL. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Autolus Therapeutics plc - American Depositary Shares stock going up?

AUTL has changed by -9.20% over the last week, -8.64% over the last month, and -44.36% over the last year. Review the chart to see whether the current move is part of a broader trend.

What was Autolus Therapeutics plc - American Depositary Shares net income for the last quarter?

Autolus Therapeutics plc - American Depositary Shares reported net income of -71.6 M for the last quarter. The previous quarter showed -90.33 M, which means net income changed by +20.74%.

How many employees does Autolus Therapeutics plc - American Depositary Shares have?

As of the latest available data, Autolus Therapeutics plc - American Depositary Shares has 752 employees. Workforce size can provide additional context about the company's scale and operations.

What is Autolus Therapeutics plc - American Depositary Shares EBITDA?

Autolus Therapeutics plc - American Depositary Shares EBITDA is -59 M, and its EBITDA margin is -225.02%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy Autolus Therapeutics plc - American Depositary Shares stock?

You can buy Autolus Therapeutics plc - American Depositary Shares (AUTL) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Autolus Therapeutics plc - American Depositary Shares stock?

Investing in Autolus Therapeutics plc - American Depositary Shares requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the AUTL chart and related analysis on metatrader.com as part of your research.

News